Becoming a Legal Medical Cannabis Patient in Canada Even though recreational cannabis will legally become available in Canada on October 17, the medical cannabis community within Canada remains strong and growing since its legal start in 2001. As of March 2018 in Canada, there are 296,792 registrations under Health Canada’s Access to Cannabis for Medical […]
Enterprise-wide license to Strainprint Analytics, Clinic Edition, will provide unparalleled medical cannabis treatment guidance.
Strainprint™ Technologies Ltd launched the Strainprint Community, Cannabis in Good Company today – a real-time, online platform that provides education and support for the growing cannabis community. The site aims to help both veteran and new users to navigate through the historical transition to legalized cannabis in Canada.
Dr. Caroline MacCallum, Dr. Danial Schecter & Dr. Dean Elterman Join Strainprint’s World-Class Medical Advisory Board TORONTO, April 17, 2018 /CNW/ – Strainprint, the leader in cannabis data & analytics, is pleased to announce that Dr. Caroline MacCallum, Dr. Danial Schecter and Dr. Dean Elterman have joined its Board of Medical Advisors. Strainprint works closely […]
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.
Strainprint™, the leader in cannabis data collection and strain efficacy reporting, is pleased to announce the launch of its Ambassador Research Program. The Strainprint Ambassador program is available to qualified researchers that use Strainprint’s revolutionary data gathering and analytics tools to conduct observational cannabis studies in relation to specific medical conditions.